Prelude Therapeutics Incorporated (PRLD) Earnings
|
Expand Research on PRLD
| Next EPS Date | 11/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +26.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | $0.14 | N/A | N/A | $33.33M | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.14 | -$0.23 | +$0.09 | $5.71M | N/A | N/A |  | | Details | |
| 5/12/26 | Q126 | -$0.13 | -$0.23 | +$0.10 | $4.58M | N/A | N/A | | | Details | |
| 3/18/26 |
Q425 | N/A | -$0.13 | N/A | N/A | $20.5M | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | -$0.37 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 | Q225 | -$0.41 | -$0.48 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 8/13/25 |
Q225 | N/A | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/6/25 |
Q125 | N/A | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A |
